7Baggers

Surgery Partners, Inc
(NASDAQ:SGRY) 

SGRY stock logo

Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and s...

Founded: 2004
Full Time Employees: 6,900
Sector: Healthcare
Industry: Medical Care Facilities

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-09-01 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
                                                
      revenues
    810,900,000 885,000,000 821,500,000 826,200,000 776,000,000 864,400,000 770,400,000 762,100,000 717,400,000 735,400,000 674,100,000 667,600,000 666,200,000 707,100,000 620,600,000 615,400,000 596,200,000 610,200,000 559,200,000 543,300,000 512,400,000 548,300,000 496,100,000 374,700,000 441,000,000 517,200,000 452,000,000 445,400,000 416,800,000 465,380,000 443,932,000 444,775,000 417,369,000 306,001,000 282,682,000  288,353,000 286,183,000 306,001,000 282,682,000 289,681,000 267,074,000 263,322,000 239,599,000 
      operating expenses:
                                                
      salaries and benefits
    247,400,000 254,400,000 242,800,000 235,200,000 238,600,000 240,700,000 228,400,000 223,200,000 215,200,000 201,400,000 195,000,000 195,200,000 202,200,000 200,100,000 185,500,000 181,900,000 178,900,000 175,600,000 162,300,000 155,300,000 151,700,000 152,100,000 141,700,000 116,100,000 140,400,000 148,800,000 139,300,000 132,700,000 129,200,000 139,544,000 131,441,000 134,020,000 129,735,000 90,774,000 85,724,000  90,022,000 89,887,000 90,774,000 85,724,000 93,791,000 86,886,000 73,280,000 66,072,000 
      supplies
    220,200,000 239,200,000 208,900,000 215,000,000 215,800,000 223,000,000 201,400,000 199,700,000 188,800,000 195,200,000 179,200,000 182,200,000 188,400,000 191,400,000 173,200,000 173,500,000 171,600,000 171,500,000 160,100,000 157,500,000 147,300,000 156,200,000 142,800,000 110,100,000 129,300,000 143,300,000 126,200,000 123,400,000 115,000,000 134,550,000 120,123,000 121,148,000 114,430,000 72,755,000 65,907,000  74,084,000 71,160,000 72,755,000 65,907,000 66,915,000 63,662,000 65,533,000 60,377,000 
      professional and medical fees
    101,300,000 103,100,000 104,000,000 102,100,000 95,300,000 91,100,000 91,000,000 92,400,000 82,600,000 76,900,000 72,400,000 72,900,000 74,600,000 70,800,000 68,100,000 66,700,000 63,600,000 60,300,000 56,800,000 57,400,000 55,500,000 53,000,000 46,300,000 45,300,000 46,800,000 44,800,000 38,500,000 36,400,000 35,100,000 38,167,000 34,902,000 36,713,000 35,679,000 20,372,000 20,856,000  22,577,000 21,125,000 20,372,000 20,856,000 20,304,000 19,654,000 18,439,000 17,233,000 
      lease expense
    23,000,000 22,700,000 21,500,000 22,900,000 20,800,000 22,000,000 23,900,000 22,200,000 21,400,000 20,600,000 21,100,000 21,800,000 21,400,000 20,600,000 21,600,000 20,200,000 20,000,000 21,800,000 23,400,000 22,600,000 22,800,000 22,700,000 21,900,000 21,500,000 21,300,000 22,600,000 21,400,000 21,000,000 20,600,000 21,763,000 21,629,000 21,920,000 21,361,000 13,435,000 13,204,000  13,674,000 13,626,000 13,435,000 13,204,000 13,074,000 12,434,000 11,581,000 11,211,000 
      other operating expenses
    58,800,000 53,400,000 49,000,000 55,400,000 43,600,000 54,000,000 48,200,000 45,400,000 54,100,000 47,700,000 40,600,000 41,400,000 45,600,000 39,900,000 41,000,000 38,500,000 37,300,000 33,900,000 34,100,000 32,200,000 31,600,000 28,900,000 29,200,000 26,300,000 28,400,000 28,500,000 27,700,000 26,900,000 26,200,000 25,716,000 26,194,000 26,289,000 26,107,000 16,911,000 15,703,000  16,095,000 16,150,000 16,911,000 15,703,000 14,768,000 14,067,000 14,341,000 13,928,000 
      cost of revenues
    650,700,000 672,800,000 626,200,000 630,600,000 614,100,000 630,800,000 592,900,000 582,900,000 562,100,000 541,800,000 508,300,000 513,500,000 532,200,000 522,800,000 489,400,000 480,800,000 471,400,000 463,100,000 436,700,000 425,000,000 408,900,000 412,900,000 381,900,000 319,300,000 366,200,000 388,000,000 353,100,000 340,400,000 326,100,000 359,740,000 334,289,000 340,090,000 327,312,000 214,247,000 201,394,000  216,452,000 211,948,000 214,247,000 201,394,000 208,852,000 196,703,000 183,174,000 168,821,000 
      general and administrative expenses
    39,300,000 23,700,000 22,400,000 36,100,000 36,000,000 36,000,000 29,200,000 40,300,000 33,200,000 20,900,000 36,800,000 31,200,000 32,000,000 28,700,000 17,900,000 26,100,000 29,500,000 27,200,000 25,500,000 24,500,000 26,800,000 23,800,000 25,200,000 25,300,000 22,800,000 23,700,000 19,900,000 23,300,000 21,700,000 23,829,000 19,478,000 26,099,000 24,152,000 18,041,000 14,985,000  18,655,000 15,541,000 18,041,000 14,985,000 15,023,000 12,197,000 21,048,000 11,236,000 
      depreciation and amortization
    38,500,000 59,900,000 39,500,000 40,300,000 36,300,000 33,900,000 50,200,000 34,800,000 33,700,000 31,100,000 28,900,000 24,400,000 33,700,000 29,600,000 29,800,000 28,000,000 27,400,000 22,700,000 25,200,000 25,200,000 25,700,000 25,500,000 24,100,000 23,400,000 21,800,000 20,200,000 18,400,000 19,100,000 18,800,000 18,061,000 16,945,000 16,685,000 15,749,000 10,567,000 9,713,000  11,417,000 11,108,000 10,567,000 9,713,000 9,702,000 9,568,000 9,007,000 8,611,000 
      transaction and integration costs
    15,600,000 18,500,000 12,600,000 18,100,000 24,700,000 34,000,000 29,400,000 19,300,000 17,400,000 24,400,000 12,800,000 12,000,000 12,500,000 19,700,000 12,500,000 8,200,000 7,100,000 15,100,000 10,200,000 9,200,000 5,300,000 7,400,000 5,400,000 4,900,000 5,500,000 7,400,000 3,400,000 6,200,000 2,000,000 7,894,000 7,099,000 11,639,000             
      net loss on disposals, consolidations and deconsolidations
    4,300,000 11,400,000 15,600,000 -3,000,000 6,400,000 19,100,000 14,700,000 5,300,000 1,500,000 6,900,000 5,800,000  10,500,000                                
      equity in earnings of unconsolidated affiliates
    -4,100,000 -6,600,000 -5,200,000 -5,500,000 -5,600,000 -7,200,000 -5,200,000 -4,400,000 -2,700,000 -4,800,000 -3,500,000 -2,600,000 -3,300,000 -4,400,000 -2,400,000 -2,600,000 -3,100,000                            
      litigation settlements
    2,500,000  5,100,000  2,200,000  500,000 500,000 -1,800,000 2,500,000 3,600,000 1,500,000 3,000,000                                
      other income
    -1,700,000 -4,900,000 -1,700,000 -2,100,000  -9,300,000 -2,200,000 -6,500,000 -2,000,000 -4,300,000 -1,200,000 -1,200,000  -9,200,000 -2,400,000 -2,600,000 -2,400,000 -12,200,000 -500,000 -2,800,000    -200,000 -1,500,000 -1,000,000  -400,000    -2,132,000 -262,000          -89,000 -330,000 
      operating income
    65,800,000 110,200,000 105,700,000 111,700,000 61,900,000 127,100,000 60,900,000 84,800,000 76,000,000 101,400,000 82,600,000 97,600,000 46,400,000 94,200,000 74,100,000 76,500,000 100,400,000 114,800,000 63,600,000 59,500,000 64,300,000 96,300,000 18,500,000 44,700,000 23,500,000 71,800,000 59,000,000 55,500,000 49,600,000 -51,889,000 45,003,000 43,561,000 41,163,000 68,407,000 42,848,000  37,739,000 41,721,000 68,407,000 42,848,000 50,948,000 34,280,000 21,128,000 44,274,000 
      yoy
    6.30% -13.30% 73.56% 31.72% -18.55% 25.35% -26.27% -13.11% 63.79% 7.64% 11.47% 27.58% -53.78% -17.94% 16.51% 28.57% 56.14% 19.21% 243.78% 33.11% 173.62% 34.12% -68.64% -19.46% -52.62% -238.37% 31.10% 27.41% 20.50% -175.85% 5.03%  9.07% 63.96% -37.36%  -25.93% 21.71% 223.77% -3.22%     
      qoq
    -40.29% 4.26% -5.37% 80.45% -51.30% 108.70% -28.18% 11.58% -25.05% 22.76% -15.37% 110.34% -50.74% 27.13% -3.14% -23.80% -12.54% 80.50% 6.89% -7.47% -33.23% 420.54% -58.61% 90.21% -67.27% 21.69% 6.31% 11.90% -195.59% -215.30% 3.31% 5.83% -39.83% 59.65%   -9.54% -39.01% 59.65% -15.90% 48.62% 62.25% -52.28%  
      interest expense
    -69,100,000 -67,600,000 -74,900,000 -67,900,000 -62,200,000 -52,900,000 -50,000,000 -51,500,000 -47,300,000 -48,700,000 -49,800,000 -47,700,000 -46,800,000 -61,000,000 -60,700,000 -56,900,000 -56,300,000 -60,100,000 -54,200,000 -53,400,000 -53,300,000 -54,000,000 -51,500,000 -49,200,000 -47,100,000 -44,800,000 -45,700,000 -46,400,000 -42,000,000 -39,635,000 -37,159,000 -35,933,000 -34,276,000 -25,708,000 -26,475,000  -25,600,000 -25,182,000 -25,708,000 -26,475,000 -26,235,000 -22,153,000 -22,473,000 -26,573,000 
      income before income taxes
    -3,300,000 42,600,000 30,800,000 43,800,000 -300,000 74,200,000 10,900,000 33,300,000 28,700,000 52,700,000 32,800,000 49,900,000 -400,000 33,200,000 13,400,000 19,600,000 44,100,000 54,700,000 9,400,000 6,100,000 11,000,000 42,300,000 -33,000,000 -4,500,000 -23,600,000 27,000,000 13,300,000 9,100,000 5,200,000 -91,524,000 7,844,000 7,628,000 6,887,000 42,699,000 12,640,000  12,139,000 16,539,000 42,699,000 12,640,000 24,713,000 12,127,000 -121,256,000 17,701,000 
      income tax benefit
    1,200,000   1,100,000  -120,800,000 -4,500,000 -4,900,000 -4,400,000 -6,000,000 -3,100,000 7,800,000 1,600,000 -9,900,000 -7,800,000 -4,300,000    -2,700,000                         
      net income
    -2,100,000 29,000,000 25,300,000 44,900,000 -300,000 -46,600,000 6,400,000 28,400,000 24,300,000 46,700,000 29,700,000 57,700,000 1,200,000 23,300,000 5,600,000 15,300,000 42,800,000 42,900,000 8,200,000 8,800,000 10,800,000 47,900,000 -34,300,000 -3,900,000 -8,400,000 22,600,000 10,900,000 8,100,000 3,500,000 -107,080,000 2,019,000 4,310,000 5,125,000 38,100,000 14,334,000  11,627,000 14,422,000 38,100,000 14,334,000 22,293,000 10,357,000 36,094,000 13,784,000 
      yoy
    600.00% -162.23% 295.31% 58.10% -101.23% -199.79% -78.45% -50.78% 1925.00% 100.43% 430.36% 277.12% -97.20% -45.69% -31.71% 73.86% 296.30% -10.44% -123.91% -325.64% -228.57% 111.95% -414.68% -148.15% -340.00% -121.11% 439.87% 87.94% -31.71% -381.05% -85.91%  -55.92% 164.18% -62.38%  -47.84% 39.25% 5.56% 3.99%     
      qoq
    -107.24% 14.62% -43.65% -15066.67% -99.36% -828.13% -77.46% 16.87% -47.97% 57.24% -48.53% 4708.33% -94.85% 316.07% -63.40% -64.25% -0.23% 423.17% -6.82% -18.52% -77.45% -239.65% 779.49% -53.57% -137.17% 107.34% 34.57% 131.43% -103.27% -5403.62% -53.16% -15.90% -86.55% 165.80%   -19.38% -62.15% 165.80% -35.70% 115.25% -71.31% 161.85%  
      less: net income attributable to non-controlling interests
    -33,800,000 -44,000,000 -48,000,000 -47,400,000 -37,400,000 -61,900,000 -38,100,000 -43,900,000 -36,700,000 -47,700,000 -34,600,000 -38,800,000 -26,100,000 -46,700,000 -30,600,000 -33,700,000 -30,600,000 -43,000,000 -31,100,000 -35,700,000 -31,800,000 -42,400,000 -27,300,000 -28,600,000 -19,100,000 -41,800,000 -26,600,000 -27,900,000 -23,600,000 -40,662,000 -23,000,000 -23,772,000 -22,646,000 -21,238,000 -16,672,000  -16,098,000 -17,176,000 -21,238,000 -16,672,000 -20,173,000 -17,547,000 -19,355,000 -16,906,000 
      net income attributable to surgery partners, inc.
    -35,900,000       -15,500,000    18,900,000 -24,900,000    12,200,000                    -4,471,000    2,120,000    
      net income per share
                                                
      basic
    -0.28 -0.11 -0.18 -0.02 -0.3 -0.86 -0.25 -0.12 -0.1  -0.04 0.15 -0.2 -0.088 -0.28 -0.21 0.14 -0.298 -0.28 -0.39 -0.57 -0.773 -1.46 -0.86 -0.76 -0.425 -0.51 -0.59 -0.6 -3.25 -0.61 -0.57 -0.53 0.35 -0.05  -0.09 -0.06 0.35 -0.05 0.04 -0.15 0.52 -0.1 
      diluted
    -0.28 -0.11 -0.18 -0.02 -0.3 -0.86 -0.25 -0.12 -0.1  -0.04 0.15 -0.2 -0.088 -0.28 -0.21 0.14 -0.298 -0.28 -0.39 -0.57 -0.773 -1.46 -0.86 -0.76 -0.425 -0.51 -0.59 -0.6 -3.25 -0.61 -0.57 -0.53 0.35 -0.05  -0.09 -0.06 0.35 -0.05 0.04 -0.15 0.52 -0.1 
      weighted-average common shares outstanding:
                                                
      basic
    128,367 127,209 127,206 126,980 126,602 126,122 126,172 126,134 125,972 125,613 125,747 125,718 125,206  88,907 88,900 87,995  80,726 69,267 54,773  48,883 48,840 48,472  48,310 48,291 48,047 48,027,875 48,037,634 48,016,264 48,006,870 48,018,944 48,019,652 48,018,944 48,145,729 48,019,652 48,018,944 48,019,652 48,019,652 48,017,226 36,066,233 32,054,089 
      diluted
    128,367 127,209 127,206 126,980 126,602 126,122 126,172 126,134 125,972 125,613 125,747 127,370 125,206  88,907 88,900 90,272  80,726 69,267 54,773  48,883 48,840 48,472  48,310 48,291 48,047 48,027,875 48,037,634 48,016,264 48,006,870 48,190,738 48,019,652 48,190,738 48,145,729 48,019,652 48,190,738 48,019,652 48,129,041 48,017,226 37,464,387 32,054,089 
      loss on debt extinguishment
      1,300,000     5,100,000           -500,000 9,600,000        11,700,000                 
      income tax expense
     -1,100,000 -5,500,000              -1,300,000 11,800,000 1,200,000  200,000 -5,600,000 1,300,000 -600,000 -15,200,000 4,400,000 2,400,000 1,000,000 1,700,000 15,556,000 5,825,000 3,318,000 1,762,000 4,599,000 -1,694,000  512,000 2,117,000 4,599,000 -1,694,000 2,420,000 1,770,000   
      net loss attributable to surgery partners, inc.
     -15,000,000 -22,700,000 -2,500,000 -37,700,000 -108,500,000 -31,700,000  -12,400,000 -1,000,000 -4,900,000   -23,400,000 -25,000,000 -18,400,000  -100,000 -22,900,000 -26,900,000 -21,000,000 5,500,000 -61,600,000 -32,500,000 -27,500,000 -19,200,000 -15,700,000 -19,800,000 -20,100,000 -14,491,000 -20,981,000 -19,462,000 -17,521,000 -1,852,250 -2,338,000   -2,754,000 -1,852,250 -2,338,000  -7,190,000 -3,827,500 -3,122,000 
      grant funds
                -1,100,000 -600,000 -500,000 -100,000 -1,200,000 -17,900,000  -4,900,000 -15,100,000 -13,000,000 9,900,000 -43,100,000                     
      weighted-average common shares outstanding
                                                
      basic
    128,367 127,209 127,206 126,980 126,602 126,122 126,172 126,134 125,972 125,613 125,747 125,718 125,206  88,907 88,900 87,995  80,726 69,267 54,773  48,883 48,840 48,472  48,310 48,291 48,047 48,027,875 48,037,634 48,016,264 48,006,870 48,018,944 48,019,652 48,018,944 48,145,729 48,019,652 48,018,944 48,019,652 48,019,652 48,017,226 36,066,233 32,054,089 
      diluted
    128,367 127,209 127,206 126,980 126,602 126,122 126,172 126,134 125,972 125,613 125,747 127,370 125,206  88,907 88,900 90,272  80,726 69,267 54,773  48,883 48,840 48,472  48,310 48,291 48,047 48,027,875 48,037,634 48,016,264 48,006,870 48,190,738 48,019,652 48,190,738 48,145,729 48,019,652 48,190,738 48,019,652 48,129,041 48,017,226 37,464,387 32,054,089 
      net (gain) loss on disposals, consolidations and deconsolidations
               -8,800,000                                 
      other expense
                300,000                 -167,000 -1,207,000   -42,000    -2,000 24,250  40,000 57,000   
      loss on disposals and deconsolidations
                 7,900,000 2,200,000 1,100,000  500,000 1,900,000 1,000,000 -900,000 -1,400,000 700,000 2,900,000 3,500,000 2,600,000 600,000 -8,200,000 600,000 15,947,000 12,631,000 3,197,000             
      litigation settlement
                 -8,200,000   -32,800,000        1,200,000                    
      less: amounts attributable to participating securities
                        -10,300,000 -10,300,000 -10,000,000 -9,700,000 -9,500,000 -9,300,000 -9,100,000 -8,800,000 -8,500,000 -8,453,000 -8,245,000 -7,956,000 -7,772,000            
      net loss attributable to common stockholders
                 -23,400,000 -25,000,000 -18,400,000  -100,000 -22,900,000 -26,900,000 -31,300,000 -4,800,000 -71,600,000 -42,200,000 -37,000,000 -28,500,000 -24,800,000 -28,600,000 -28,600,000 -20,484,250 -29,226,000 -27,418,000 -25,293,000            
      gain on disposals and deconsolidations
                    -100,000                            
      net income attributable to common stockholders
                    12,200,000                            
      income from equity investments
                     -2,800,000 -2,900,000 -3,000,000 -2,600,000 -3,200,000 -3,100,000 -2,500,000 -2,000,000 -3,600,000 -2,400,000 -2,200,000 -2,000,000 -2,615,000 -1,861,000 -2,560,000 -1,862,000 -1,757,000 -1,167,000  -1,052,000 -1,200,000 -1,757,000 -1,167,000 -1,082,000 -758,000 -911,000 -1,320,000 
      impairment charges
                          33,500,000                      
      total operating expenses
                     495,400,000 495,600,000 483,800,000 448,100,000 452,000,000 477,600,000 330,000,000 417,500,000 445,400,000 393,000,000 389,900,000 367,200,000 517,269,000 398,929,000 401,214,000 376,206,000 237,594,000 239,834,000  250,614,000 244,462,000 237,594,000 239,834,000 238,733,000 232,794,000 242,194,000 195,325,000 
      tax receivable agreement expense
                             -600,000   -2,400,000     -933,250 -3,733,000     -3,733,000     
      provision for doubtful accounts
                                 6,447,000 11,555,000 8,196,000 6,037,000 8,281,000 8,514,000  5,788,000 5,675,000 8,281,000 8,514,000 3,544,000 3,873,000 7,529,000 5,840,000 
      loss on debt refinancing
                                      3,595,000     3,595,000  8,281,000   
      gain on litigation settlement
                                        -3,794,000        
      gain on acquisition escrow release
                                                
      gain on amendment to tax receivable agreement
                                                
      loss on disposal or impairment of long-lived assets
                                    47,000 658,000 572,000  405,000 1,196,000 658,000 572,000 1,331,000 -206,000 -575,000 1,161,000 
      merger transaction and integration costs
                                    5,033,000 2,377,000 1,864,000  2,904,000 337,000 2,377,000 1,864,000 1,325,000 3,172,000 3,023,000 1,249,000 
      electronic health records incentive expense
                                     -677,000 364,000          
      electronic health records incentive income
                                        -161,000 -141,000   -2,000 -93,000   
      electronic health records incentive
                                          67,250 364,000     
      electronic records incentives
                                              26,750 57,000 
      provision for income taxes
                                              2,092,000 3,917,000 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 
                                                 
        assets
                                                 
        current assets:
                                                 
        cash and cash equivalents
      182,300,000 239,900,000 203,400,000 250,100,000 229,300,000 269,500,000 221,800,000 213,500,000 185,200,000 195,900,000 236,000,000 177,400,000 245,500,000 282,900,000 154,800,000 227,400,000 378,900,000 389,900,000 330,400,000 464,800,000 541,900,000 317,900,000 450,000,000 326,300,000 194,600,000 92,700,000 111,300,000 117,400,000 142,500,000 184,308,000 79,123,000 96,069,000 112,816,000 174,914,000 199,701,000 57,034,000 55,966,000 69,699,000 55,209,000 51,599,000 135,047,000 57,933,000 56,848,000 
        accounts receivable
      603,400,000 602,200,000 579,300,000 563,100,000 570,600,000 579,100,000 542,900,000 523,400,000 494,300,000 496,400,000 462,800,000 449,900,000 452,900,000 456,300,000 422,300,000 412,000,000 412,400,000 430,200,000 393,400,000 374,900,000 367,000,000 382,200,000 337,000,000 310,900,000 311,700,000 326,900,000 303,100,000 301,900,000 294,900,000               
        inventories
      100,500,000 96,600,000 92,300,000 87,300,000 88,100,000 88,400,000 82,000,000 80,900,000 77,000,000 75,200,000 69,400,000 70,300,000 71,800,000 71,400,000 68,600,000 64,000,000 62,900,000 61,100,000 59,300,000 57,300,000 56,100,000 56,400,000 50,900,000 49,000,000 49,000,000 46,300,000 44,400,000 44,000,000 43,800,000 43,363,000 44,360,000 45,700,000 48,101,000 44,951,000 44,523,000 29,680,000 29,343,000 28,777,000 26,867,000 25,931,000 26,552,000 25,591,000 24,747,000 
        prepaid expenses
      38,800,000 41,100,000 44,700,000 45,900,000 36,300,000 36,400,000 45,200,000 44,700,000 31,700,000 31,000,000 34,700,000 39,300,000 29,300,000 31,400,000 36,000,000 37,400,000 32,200,000 25,600,000 29,800,000 28,300,000 21,100,000 17,600,000 19,200,000 23,300,000  17,800,000    16,225,000              
        other current assets
      157,500,000 170,900,000 182,500,000 158,900,000 150,300,000 146,000,000 143,900,000 150,000,000 107,700,000 96,500,000 73,300,000 73,300,000 69,400,000 79,000,000 56,600,000 47,600,000 50,600,000 39,300,000 28,800,000 27,600,000 31,700,000 27,400,000 36,300,000 37,000,000  41,800,000    36,784,000              
        total current assets
      1,082,500,000 1,150,700,000 1,102,200,000 1,105,300,000 1,074,600,000 1,119,400,000 1,035,800,000 1,012,500,000 895,900,000 895,000,000 876,200,000 810,200,000 868,900,000 921,000,000 738,300,000 788,400,000 937,000,000 946,100,000 841,700,000 952,900,000 1,017,800,000 801,500,000 893,400,000 746,500,000 614,600,000 525,500,000 517,900,000 529,000,000 535,300,000 588,322,000 463,318,000 472,799,000 490,579,000 563,225,000 573,659,000 352,311,000 350,077,000 361,955,000 328,728,000 316,950,000 394,886,000 310,957,000 288,003,000 
        property and equipment
      1,134,900,000 1,153,400,000 1,164,000,000 1,179,500,000 1,151,100,000 1,088,300,000 1,004,500,000 1,005,800,000 982,800,000 968,700,000 939,700,000 826,000,000 844,300,000 876,600,000 873,600,000 789,100,000 778,900,000 629,700,000 542,100,000 543,900,000 544,300,000 544,600,000 497,700,000 504,300,000 513,900,000 523,300,000 408,200,000 400,100,000 400,100,000 426,286,000 420,013,000 411,880,000 400,385,000 398,536,000 388,697,000 205,744,000 204,669,000 204,253,000 199,602,000 196,772,000 191,653,000 184,550,000 173,813,000 
        goodwill and other intangible assets
      5,245,000,000  5,134,600,000 5,140,000,000 5,171,400,000  4,861,500,000 4,858,500,000 4,451,100,000  4,301,000,000 4,291,200,000 4,252,600,000  4,186,500,000 4,035,600,000 3,967,800,000  3,659,300,000 3,533,900,000 3,517,500,000  3,389,400,000 3,454,600,000 3,443,300,000                   
        investments in and advances to affiliates
      225,400,000 234,000,000 229,400,000 220,200,000 218,600,000 215,400,000 214,800,000 227,100,000 188,700,000 184,100,000 196,300,000 192,200,000 191,600,000 190,300,000 189,100,000 159,700,000 94,500,000 88,700,000 89,600,000 90,200,000 90,400,000 90,300,000 91,800,000 91,100,000 90,600,000 93,200,000 93,000,000 93,400,000 78,500,000 78,477,000 80,785,000 78,133,000 75,194,000 74,282,000 64,427,000 34,488,000 35,114,000 34,980,000 34,274,000 34,715,000 34,475,000 34,103,000 33,877,000 
        right-of-use operating lease assets
      281,500,000 289,200,000 275,700,000 271,700,000 277,700,000 295,700,000 297,500,000 266,900,000 257,700,000 255,300,000 244,500,000 267,200,000 274,000,000 279,100,000 277,000,000 277,800,000 277,400,000 324,100,000 320,500,000 318,800,000 305,400,000 310,100,000 314,900,000 311,700,000 293,100,000                   
        other long-term assets
      72,800,000 56,800,000 40,700,000 38,100,000 55,800,000 57,500,000 41,100,000 36,000,000 112,400,000 103,300,000 117,400,000 128,100,000 118,600,000 144,200,000 169,100,000 130,600,000 120,000,000 59,100,000 50,300,000 51,100,000 36,200,000 27,000,000 20,200,000 21,700,000 21,400,000 328,500,000 344,100,000 313,000,000 318,800,000 36,850,000 39,675,000 51,481,000 52,379,000 48,350,000 19,133,000 15,634,000 15,974,000 16,435,000 13,830,000 11,429,000 11,248,000 8,504,000 7,510,000 
        total assets
      8,042,100,000 8,119,700,000 7,946,600,000 7,954,800,000 7,949,200,000 7,890,000,000 7,534,400,000 7,488,600,000 6,975,600,000 6,876,700,000 6,780,100,000 6,620,600,000 6,643,300,000 6,682,100,000 6,536,500,000 6,291,600,000 6,289,500,000 6,117,600,000 5,631,600,000 5,620,600,000 5,639,000,000 5,413,200,000 5,312,900,000 5,244,700,000 5,090,900,000 5,018,900,000 4,917,500,000 4,890,900,000 4,880,900,000 4,676,267,000 4,558,664,000 4,583,730,000 4,594,884,000 4,622,773,000 4,601,854,000 2,671,487,000 2,289,733,000 2,304,958,000 2,248,725,000 2,213,523,000 2,202,340,000 2,106,684,000 1,891,522,000 
        liabilities and stockholders' equity
                                                 
        current liabilities:
                                                 
        accounts payable
      168,600,000 208,700,000 174,600,000 174,900,000 165,000,000 208,700,000 170,800,000 174,000,000 174,100,000 171,800,000 148,800,000 131,500,000 144,400,000 151,600,000 138,400,000 126,400,000 122,900,000 124,900,000 116,500,000 109,100,000 96,000,000 100,200,000 90,300,000 104,700,000 106,800,000 96,700,000 85,100,000 71,700,000 69,700,000 83,292,000 76,979,000 76,161,000 80,960,000 84,710,000 73,251,000 48,210,000 47,587,000 49,766,000 44,453,000 43,874,000 45,557,000 45,341,000 40,807,000 
        accrued payroll and benefits
      77,100,000 64,900,000 69,900,000 59,300,000 67,000,000 60,400,000 64,900,000 63,100,000 68,600,000 73,800,000 82,300,000 64,300,000 67,800,000 68,900,000 69,300,000 83,800,000 83,800,000 77,100,000 73,100,000 75,600,000 67,300,000 65,400,000 65,600,000 57,900,000 41,300,000 54,200,000 45,900,000 45,900,000 41,000,000 55,212,000 41,563,000 48,749,000 36,836,000 49,625,000 42,439,000 27,437,000 25,560,000 29,273,000 24,717,000 28,855,000 26,361,000 26,307,000 23,391,000 
        other current liabilities
      235,600,000 242,600,000 238,500,000 229,100,000 233,500,000 253,900,000 242,200,000 222,300,000 203,500,000 204,100,000 208,200,000 198,100,000 200,000,000 206,900,000 291,800,000 221,800,000 221,100,000 210,000,000 208,300,000 199,000,000 241,300,000 217,000,000 232,900,000 220,400,000 203,300,000 191,200,000 199,200,000 193,900,000 191,800,000 155,243,000 122,938,000 118,206,000 113,570,000 109,944,000 106,279,000 72,465,000 83,713,000 68,993,000 71,091,000 72,069,000 70,710,000 68,410,000 70,247,000 
        current maturities of long-term debt
      100,400,000 99,300,000 103,000,000 110,000,000 103,900,000 101,400,000 97,300,000 92,400,000 77,200,000 73,300,000 62,100,000 64,700,000 62,900,000 62,800,000 116,900,000 68,300,000 68,000,000 60,400,000 60,800,000 69,600,000 61,200,000 64,400,000 61,100,000 63,500,000 60,300,000 56,000,000 51,300,000 57,300,000 57,100,000 55,552,000 54,106,000 53,650,000 54,386,000 58,726,000 48,472,000 29,919,000 28,722,000 27,822,000 29,105,000 28,738,000 27,169,000 27,272,000 27,678,000 
        total current liabilities
      581,700,000 615,500,000 586,000,000 573,300,000 569,400,000 624,400,000 575,200,000 551,800,000 523,400,000 523,000,000 501,400,000 458,600,000 475,100,000 493,400,000 624,300,000 521,700,000 542,300,000 536,800,000 540,500,000 531,900,000 574,800,000 556,800,000 590,900,000 571,200,000 411,700,000 398,100,000 381,500,000 368,800,000 359,600,000 349,299,000 295,586,000 296,766,000 285,752,000 303,005,000 275,012,000 186,002,000 196,456,000 186,725,000 178,654,000 182,437,000 183,781,000 181,314,000 176,177,000 
        long-term debt, less current maturities
      3,613,500,000 3,602,900,000 3,460,600,000 3,465,200,000 3,446,900,000 3,268,900,000 3,094,200,000 3,039,700,000 2,793,800,000 2,701,800,000 2,640,200,000 2,504,800,000 2,530,900,000 2,559,000,000 3,102,600,000 3,019,400,000 3,025,200,000 2,878,400,000 2,791,900,000 2,786,100,000 2,789,500,000 2,792,400,000 2,761,300,000 2,622,500,000 2,626,500,000 2,524,700,000 2,403,000,000 2,397,400,000 2,384,600,000 2,270,898,000 2,118,567,000 2,122,629,000 2,122,447,000 2,130,556,000 2,144,862,000 1,795,265,000 1,396,042,000 1,414,421,000 1,357,824,000 1,325,778,000 1,328,739,000 1,230,328,000 1,370,991,000 
        right-of-use operating lease liabilities
      271,900,000 279,900,000 266,300,000 263,700,000 272,900,000 292,100,000 286,400,000 257,600,000 250,500,000 248,900,000 240,900,000 264,100,000 268,800,000 271,400,000 269,800,000 271,800,000 272,100,000 315,600,000 312,400,000 310,800,000 295,400,000 300,900,000 306,100,000 298,900,000 279,100,000                   
        long-term deferred tax liabilities
      52,100,000 53,400,000 42,600,000 37,400,000 38,900,000 39,200,000                                     59,749,000 
        other long-term liabilities
      41,600,000 41,200,000 38,100,000 36,300,000 34,600,000 30,200,000 30,300,000 21,100,000 46,300,000 41,100,000 78,900,000 82,200,000 80,200,000 75,400,000 95,600,000 96,400,000 95,800,000 87,000,000 124,400,000 151,700,000 126,100,000 139,700,000 124,900,000 127,300,000 129,900,000 396,700,000 426,300,000 387,100,000 370,000,000 271,187,000 247,311,000 246,269,000 233,524,000 178,689,000 116,799,000 76,101,000 75,889,000 76,266,000 87,429,000 87,290,000 86,110,000 85,613,000 83,778,000 
        non-controlling interests—redeemable
      383,400,000 395,500,000 411,000,000 422,400,000 430,500,000 438,800,000 436,400,000 442,100,000 323,700,000 327,400,000 332,200,000 328,100,000 345,800,000 342,000,000 338,800,000 341,800,000 341,500,000 330,200,000 310,400,000 312,800,000 308,200,000 306,800,000 304,700,000 314,700,000 315,800,000 321,000,000 314,500,000 316,000,000 314,600,000 326,592,000 317,541,000 320,948,000 313,643,000 299,316,000 271,416,000 176,252,000 179,389,000 180,521,000 182,298,000 182,667,000 183,028,000 183,439,000 183,581,000 
        stockholders' equity:
                                                 
        preferred stock, 0.01 par value...
                                                 
        common stock, 0.01 par value...
      1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 1,300,000 900,000 900,000 900,000 900,000 800,000 800,000 600,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 500,000 489,000 489,000 489,000 489,000 487,000 488,000 488,000 488,000 485,000 485,000 485,000 485,000 482,000 339,000 
        additional paid-in capital
      2,548,300,000 2,540,600,000 2,542,800,000 2,537,800,000 2,525,900,000 2,520,900,000 2,513,500,000 2,511,100,000 2,495,600,000 2,497,600,000 2,494,500,000 2,501,400,000 2,478,100,000 2,478,000,000 1,623,100,000 1,618,800,000 1,625,200,000 1,622,300,000 1,306,000,000 1,298,400,000 843,300,000 607,900,000   655,300,000 662,700,000 670,300,000 677,800,000 673,900,000 673,619,000 671,252,000 675,857,000 689,012,000 695,560,000 704,054,000 324,340,000 321,820,000 320,543,000 319,397,000 318,764,000 317,622,000 316,294,000 59,766,000 
        accumulated other comprehensive income
      -10,500,000 -13,800,000 -14,400,000 -13,300,000 -11,800,000 4,800,000 10,500,000 37,100,000 52,000,000 57,500,000 77,000,000 78,800,000 64,900,000 76,200,000 82,800,000 44,300,000 25,300,000                           
        retained deficit
      -851,100,000 -815,200,000 -800,200,000 -777,500,000 -775,000,000 -737,300,000 -628,800,000 -597,100,000 -581,600,000 -569,200,000 -568,200,000 -563,300,000 -582,300,000 -557,300,000 -533,900,000 -508,900,000 -490,500,000 -502,700,000 -502,600,000 -479,700,000 -452,800,000 -431,800,000   -343,200,000 -315,700,000 -284,600,000 -268,900,000 -249,100,000 -247,022,000 -99,280,000 -78,299,000 -58,837,000 -41,316,000 -9,140,000 -318,576,000 -314,105,000 -311,351,000 -328,213,000 -325,875,000 -327,994,000 -320,804,000 -337,543,000 
        total surgery partners, inc. stockholders' equity
      1,688,000,000 1,712,900,000 1,729,500,000 1,748,300,000 1,740,400,000 1,789,700,000 1,896,500,000 1,952,400,000 1,967,300,000 1,987,200,000 2,004,600,000 2,018,200,000 1,962,000,000 1,998,200,000 1,172,900,000 1,155,100,000 1,160,900,000 1,089,000,000 756,300,000 765,100,000 336,500,000 115,600,000 101,200,000 204,400,000 236,700,000 296,800,000 328,700,000 358,700,000 391,400,000 404,640,000 571,072,000 598,047,000 630,664,000 654,731,000 695,402,000 6,252,000 8,203,000 9,677,000      
        non-controlling interests—non-redeemable
      1,409,900,000 1,418,400,000 1,412,500,000 1,408,200,000 1,415,600,000 1,406,700,000 1,215,400,000 1,223,900,000 1,070,600,000 1,047,300,000 981,900,000 964,600,000 980,500,000 942,700,000 932,500,000 885,400,000 851,700,000 880,600,000 795,700,000 762,200,000 768,800,000 766,500,000 699,600,000 691,500,000 686,700,000 686,600,000 677,800,000 686,300,000 692,900,000 694,305,000 657,694,000 656,423,000 674,162,000 681,879,000 683,733,000 309,264,000 311,403,000 314,997,000 325,808,000 320,237,000 302,121,000 301,955,000 294,684,000 
        total stockholders' equity
      3,097,900,000 3,131,300,000 3,142,000,000 3,156,500,000 3,156,000,000 3,196,400,000 3,111,900,000 3,176,300,000 3,037,900,000 3,034,500,000 2,986,500,000 2,982,800,000 2,942,500,000 2,940,900,000 2,105,400,000 2,040,500,000 2,012,600,000 1,969,600,000 1,552,000,000 1,527,300,000 1,105,300,000 882,100,000 800,800,000 895,900,000 923,400,000 983,400,000 1,006,500,000 1,045,000,000 1,084,300,000 1,098,945,000 1,228,766,000 1,254,470,000 1,304,826,000 1,336,610,000 1,379,135,000 315,516,000 319,606,000 324,674,000 317,477,000 313,611,000 292,234,000 297,927,000 17,246,000 
        total liabilities and stockholders' equity
      8,042,100,000 8,119,700,000 7,946,600,000 7,954,800,000 7,949,200,000 7,890,000,000 7,534,400,000 7,488,600,000 6,975,600,000 6,876,700,000 6,780,100,000 6,620,600,000 6,643,300,000 6,682,100,000 6,536,500,000 6,291,600,000 6,289,500,000 6,117,600,000 5,631,600,000 5,620,600,000 5,639,000,000 5,413,200,000 5,312,900,000 5,244,700,000 5,090,900,000 5,018,900,000 4,917,500,000 4,890,900,000 4,880,900,000 4,676,267,000 4,558,664,000 4,583,730,000 4,594,884,000 4,622,773,000 4,601,854,000 2,671,487,000 2,289,733,000 2,304,958,000 2,248,725,000 2,213,523,000 2,202,340,000 2,106,684,000 1,891,522,000 
        intangible assets
       41,000,000    45,700,000    54,800,000    42,300,000    43,700,000    46,900,000    47,300,000 52,600,000 53,600,000 54,300,000 54,293,000 55,607,000 61,422,000 62,412,000 58,908,000 56,507,000 43,421,000 45,753,000 48,023,000 48,673,000 51,487,000 51,166,000 53,568,000 53,137,000 
        goodwill
       5,194,600,000    5,068,000,000    4,326,000,000    4,137,100,000    3,911,800,000    3,468,000,000    3,402,400,000 3,405,600,000 3,402,300,000 3,393,000,000 3,382,846,000 3,372,606,000 3,376,295,000 3,382,801,000 3,346,838,000 3,270,309,000 1,569,408,000 1,556,504,000 1,555,204,000 1,531,370,000 1,510,851,000 1,417,991,000 1,407,927,000 1,330,050,000 
        long-term deferred tax assets
            79,200,000 81,800,000 87,000,000 89,500,000 105,000,000 105,700,000 93,300,000 91,500,000 102,900,000 110,400,000 113,900,000 114,400,000 128,100,000 129,800,000 127,400,000 124,800,000 105,500,000 114,800,000 114,000,000 98,700,000 96,100,000 99,500,000 100,900,000 109,193,000 126,660,000 131,720,000 130,819,000 132,319,000 209,207,000 80,166,000 81,327,000 83,793,000 90,233,000 88,919,000 91,813,000 94,105,000  
        medicare accelerated payments and deferred governmental grants
                   3,200,000 7,900,000 21,400,000 46,500,000 64,400,000 81,800,000 78,600,000 109,000,000 109,800,000 141,000,000 124,700,000                    
        redeemable preferred stock - series a; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - none and 434.5, respectively
                                                 
        accumulated other comprehensive loss
                       -31,500,000 -47,900,000 -54,400,000 -54,600,000 -61,000,000   -75,900,000 -50,700,000 -57,500,000 -50,700,000 -33,900,000 -22,446,000 -1,389,000             
        redeemable preferred stock - series a; shares authorized - 310,000; shares issued or outstanding - none and 310,000, respectively; redemption value - — and 434.5, respectively
                                                 
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 439.7 and 434.5, respectively
                          439,700,000                       
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 434.5 and 395.0, respectively
                           434,500,000                      
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 424.2 and 395.0, respectively
                            424,200,000                     
        other stockholders' equity
                            100,700,000 203,900,000                    
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 414.2 and 395.0, respectively
                             414,200,000                    
        prepaid expenses and other current assets
                              59,300,000  59,100,000 65,700,000 54,100,000  53,575,000 54,181,000 54,324,000 55,337,000 53,724,000 42,332,000 35,879,000 32,014,000 30,313,000 26,704,000 32,346,000 34,620,000 26,678,000 
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 404.5 and 395.0, respectively
                              404,500,000                   
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 395.0 and 359.3, respectively
                               395,000,000                  
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 385.7 and 359.3, respectively
                                385,700,000                 
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 376.6 and 359.3, respectively
                                 376,600,000                
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 367.8 and 359.3, respectively
                                  367,800,000               
        accounts receivables
                                   307,642,000 286,260,000 276,849,000 275,338,000 288,023,000 271,140,000 215,294,000 218,015,000 220,594,000 205,979,000 202,743,000 185,885,000 177,757,000 164,604,000 
        redeemable preferred stock - series a; shares authorized, issued and outstanding - 310,000; redemption value - 359,346 and 330,806, respectively
                                   359,346,000              
        redeemable preferred stock - series a, 310,000 shares authorized, issued and outstanding at both september 30, 2018 and december 31, 2017; redemption value of 350,893 and 330,806, respectively
                                    350,893,000             
        redeemable preferred stock - series a, 310,000 shares authorized, issued and outstanding at both june 30, 2018 and december 31, 2017; redemption value of 342,648 and 330,806, respectively
                                     342,648,000            
        restricted invested assets
                                      315,000 315,000 315,000 315,000 315,000 315,000 315,000 315,000 315,000 316,000 316,000 
        redeemable preferred stock - series a, 310,000 shares authorized, issued and outstanding at both march 31, 2018 and december 31, 2017; redemption value of 334,692 and 330,806, respectively
                                      334,692,000           
        long-term tax receivable agreement liability
                                       43,791,000 68,148,000 122,351,000 122,351,000 122,351,000 123,343,000 119,655,000 119,655,000 119,655,000  
        redeemable preferred stock - series a, 310,000 shares authorized, issued and outstanding, redemption value of 330,806 at december 31, 2017; no shares were authorized, issued or outstanding at december 31, 2016.
                                       330,806,000          
        acquisition escrow deposit
                                        4,571,000 7,971,000 10,874,000 10,871,000 9,288,000 8,901,000 13,984,000 13,984,000 14,054,000 
        long-term acquisition escrow deposit
                                        19,600,000    1,700,000 2,085,000 8,793,000   
        acquisition escrow liability
                                        4,571,000 7,971,000 10,874,000 10,871,000 9,288,000 8,901,000 13,984,000 13,984,000 14,054,000 
        long-term acquisition escrow liability
                                        19,600,000    1,700,000 2,085,000 8,793,000   
        redeemable preferred stock - series a, 310,000 shares authorized, issued and outstanding, redemption value of 326,882 at september 30, 2017; no shares were authorized issued or outstanding at december 31, 2016.
                                        326,882,000         
        financing escrow asset
                                         370,000,000        
        indemnification receivable due from seller
                                            1,072,000 1,072,000 1,072,000 1,072,000 1,072,000 
        total surgery partners, inc. stockholders' deficit
                                            -8,331,000 -6,626,000 -9,887,000 -4,028,000 -277,438,000 
        debt issuance costs
                                               4,246,000 4,816,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-01 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 
                                                  
          cash flows from operating activities:
                                                  
          net income
        -2,100,000 29,000,000 25,300,000 44,900,000 -300,000 -46,600,000 6,400,000 28,400,000 24,300,000 46,700,000 29,700,000 57,700,000 1,200,000 23,300,000 5,600,000 15,300,000 42,800,000 42,900,000 8,200,000 8,800,000 10,800,000 47,900,000 -34,300,000 -3,900,000 -8,400,000 22,600,000 10,900,000 8,100,000 3,500,000 -107,080,000 2,019,000 4,310,000 5,125,000 966,000 -28,697,000 11,627,000 14,422,000 38,100,000 14,334,000 22,292,000 10,357,000 36,094,000 
          adjustments to reconcile net income to net cash from operating activities:
                                                  
          depreciation and amortization
        38,500,000 59,900,000 39,500,000 40,300,000 36,300,000 33,900,000 50,200,000 34,800,000 33,700,000 31,100,000 28,900,000 24,400,000 33,700,000 29,600,000 29,800,000 28,000,000 27,400,000 22,700,000 25,200,000 25,200,000 25,700,000 25,500,000 24,100,000 23,400,000 21,800,000 20,200,000 18,400,000 19,100,000 18,800,000 18,061,000 16,945,000 16,685,000 15,749,000 18,474,000 -19,195,000 11,417,000 11,108,000 10,567,000 9,713,000 9,703,000 9,568,000 9,007,000 
          non-cash lease expense
        11,200,000 8,700,000 9,600,000 9,900,000 9,600,000 9,700,000 10,500,000 9,700,000 9,000,000 8,800,000 8,500,000 8,900,000 9,000,000 8,000,000 9,700,000 8,500,000 8,600,000 8,800,000 10,300,000 10,200,000 9,800,000 10,000,000 9,300,000 10,700,000 9,400,000   9,500,000 10,100,000              
          non-cash interest expense
        2,300,000 3,400,000 2,200,000 1,500,000 2,500,000 1,700,000 1,700,000 1,600,000 1,500,000 5,200,000 6,700,000 6,600,000 6,500,000 6,900,000 6,600,000 6,300,000 6,100,000 10,000,000 6,300,000 4,100,000 1,600,000 1,400,000 900,000 900,000 1,300,000 1,900,000 500,000   -374,000 -387,000            
          equity-based compensation expense
        5,800,000 -2,200,000 2,600,000 6,800,000 7,600,000 6,200,000 7,100,000 15,100,000 4,900,000 4,500,000 4,400,000 4,600,000 4,200,000 5,400,000 5,000,000 4,300,000 3,700,000 4,000,000 4,100,000 4,100,000 5,200,000 3,300,000 3,000,000 3,400,000 3,500,000 2,600,000 2,700,000                
          net loss on disposals, consolidations and deconsolidations
        4,300,000 11,400,000 15,600,000 -3,000,000 6,400,000 19,100,000 14,700,000 5,300,000 1,500,000 6,900,000   10,500,000                              
          deferred income taxes
        -1,300,000 13,400,000 5,100,000 -1,500,000 -300,000 121,200,000 2,700,000 5,100,000 2,500,000 9,100,000 700,000 -9,700,000 -1,800,000 9,500,000 7,500,000 3,900,000 1,000,000 11,200,000 900,000 -3,100,000 -100,000 -6,600,000 1,100,000 -900,000 -15,500,000 4,400,000 2,100,000 700,000 1,300,000 15,808,000 5,637,000 2,475,000 1,352,000 71,496,000 -2,359,000 88,000 1,806,000 4,979,000 -1,987,000 2,405,000 1,485,000 -157,310,000 
          equity in earnings of unconsolidated affiliates, net of distributions received
        2,600,000 -1,800,000 800,000 -900,000 1,100,000 -2,300,000 100,000 -800,000 1,000,000 500,000 -1,900,000 -600,000 -200,000 -1,300,000 -100,000 500,000 -900,000                          
          changes in operating assets and liabilities, net of acquisitions and divestitures:
                                                  
          accounts receivable
        3,600,000 -46,100,000 -16,200,000 3,700,000 4,800,000 -40,900,000 -19,100,000 -17,500,000 5,400,000 -29,000,000 -13,100,000 -13,900,000 8,800,000 -38,700,000 -2,000,000 3,400,000 2,000,000 -13,700,000 -15,300,000 -7,000,000 3,900,000 -34,700,000 -28,200,000 800,000 15,500,000 -31,200,000 800,000 -6,500,000 13,400,000 846,000 -22,204,000 -9,544,000 8,083,000 -28,705,000 2,904,000 -2,266,000 -3,433,000 -22,142,000 -12,578,000 -13,356,000 -12,546,000 -14,245,000 
          other operating assets and liabilities
        -53,200,000 27,700,000 -2,200,000 -20,400,000 -61,700,000 9,400,000 -9,100,000 -4,000,000 -43,100,000 -36,700,000 34,900,000 -17,100,000 3,800,000 -46,100,000 -21,100,000 -7,000,000 7,200,000 -41,300,000 -7,100,000 3,400,000 1,600,000 -32,200,000 1,300,000 20,600,000 -2,400,000 -16,600,000 11,300,000 -11,000,000 -29,000,000 50,297,000 1,641,000 12,571,000 -8,529,000 17,413,000 4,611,000 -9,366,000 1,836,000 3,127,000 -10,074,000 20,788,000 3,362,000 -550,000 
          net cash from operating activities
        11,700,000 103,400,000 83,600,000 81,300,000 6,000,000 111,400,000 65,200,000 82,800,000 40,700,000 62,600,000 104,600,000 52,100,000 74,500,000 7,200,000 29,700,000 42,100,000 79,800,000 19,700,000 14,900,000 2,300,000 50,200,000 8,900,000 26,900,000 181,900,000 29,200,000 25,400,000 56,900,000 26,700,000 20,500,000 45,546,000 29,414,000 39,584,000 30,056,000 54,447,000 -57,693,000 21,601,000 34,870,000 32,376,000 18,826,000 48,793,000 25,244,000 24,189,000 
          capital expenditures
        -16,000,000 -12,800,000 -19,800,000 -23,400,000 -22,700,000 -22,300,000 -20,200,000 -26,900,000 -21,000,000 -19,800,000 -18,900,000 -25,800,000 -24,300,000 -22,700,000 -17,300,000 -22,400,000 -18,200,000 -14,100,000 -15,500,000 -13,500,000 -14,500,000 -15,100,000 -7,900,000 -8,100,000 -11,800,000 -23,400,000 -18,400,000 -20,000,000 -11,800,000 -13,187,000 -10,675,000 -5,960,000 -5,955,000 -8,987,000 13,262,000 -8,752,000 -6,350,000 -10,732,000 -8,027,000 -8,546,000 -11,804,000 -15,324,000 
          free cash flows
        -4,300,000 90,600,000 63,800,000 57,900,000 -16,700,000 89,100,000 45,000,000 55,900,000 19,700,000 42,800,000 85,700,000 26,300,000 50,200,000 -15,500,000 12,400,000 19,700,000 61,600,000 5,600,000 -600,000 -11,200,000 35,700,000 -6,200,000 19,000,000 173,800,000 17,400,000 2,000,000 38,500,000 6,700,000 8,700,000 32,359,000 18,739,000 33,624,000 24,101,000 45,460,000 -44,431,000 12,849,000 28,520,000 21,644,000 10,799,000 40,247,000 13,440,000 8,865,000 
          cash flows from investing activities:
                                                  
          purchases of property and equipment
        -16,000,000 -12,800,000 -19,800,000 -23,400,000 -22,700,000 -22,300,000 -20,200,000 -26,900,000 -21,000,000 -19,800,000 -18,900,000 -25,800,000 -24,300,000 -22,700,000 -17,300,000 -22,400,000 -18,200,000 -14,100,000 -15,500,000 -13,500,000 -14,500,000 -15,100,000 -7,900,000 -8,100,000 -11,800,000 -23,400,000 -18,400,000 -20,000,000 -11,800,000 -13,187,000 -10,675,000 -5,960,000 -9,983,000 -8,987,000 13,262,000 -8,752,000 -6,350,000 -10,732,000 -8,027,000 -8,546,000 -11,804,000 -15,324,000 
          payments for acquisitions, net of cash acquired
        -4,200,000 -109,500,000 -4,600,000 -4,000,000 -44,000,000 -87,600,000 -26,600,000 -210,000,000 -54,600,000 -31,200,000 -5,300,000 -2,800,000 -40,700,000 -63,800,000 -7,700,000 -43,800,000 -31,100,000 -184,800,000 -85,800,000 -13,100,000 -2,100,000 -90,400,000 -1,800,000 -6,900,000 -5,500,000 -600,000 -5,600,000 -7,600,000 -51,559,000 -7,319,000 -22,305,000 -25,589,000 -28,086,000 13,000,000 -13,888,000 -275,000 -20,387,000 -13,001,000 -105,968,000 -7,049,000 -80,034,000 
          proceeds from disposals of facilities and other assets
         3,600,000 38,100,000 4,800,000 1,100,000 1,500,000 -300,000 18,100,000 8,000,000     3,500,000 200,000 2,300,000 10,200,000 38,900,000 9,400,000  16,400,000 1,200,000              
          purchases of equity investments
         100,000 -9,600,000 -3,800,000 300,000 -2,000,000 -100,000 -1,800,000 -38,800,000 -9,600,000 -29,300,000                           
          proceeds from sales of equity investments
        900,000     600,000   400,000    1,300,000 11,500,000                          
          other investing activities
        5,900,000 -9,000,000 -12,200,000 -8,600,000 -10,700,000 -3,500,000 -2,800,000 -11,500,000 -7,000,000 -7,400,000 -300,000 -21,900,000 -4,100,000 100,000 -2,300,000 -9,300,000    100,000 100,000 200,000 200,000 100,000 -100,000 -200,000 1,356,000 -1,595,000 -374,000 -842,000          
          net cash from investing activities
        -13,400,000 -126,100,000 -46,200,000 2,100,000 -76,400,000 -111,700,000 -49,600,000 -244,100,000 -83,100,000 -58,100,000 -25,600,000 -71,200,000 -70,700,000 -72,200,000 -54,300,000 -134,300,000 -47,100,000 -190,000,000 -101,000,000 -26,400,000 -14,300,000 -95,200,000 29,300,000 -14,800,000 -7,700,000 -23,400,000 -18,900,000 -24,500,000 -18,400,000 -62,251,000 -11,789,000 -18,408,000 -36,414,000 -35,890,000 26,192,000 -22,570,000 -6,625,000 -30,354,000 -21,028,000 -114,514,000 -18,853,000 -95,358,000 
          cash flows from financing activities:
                                                  
          principal payments on long-term debt
        -193,800,000 -579,400,000 -161,000,000 -180,100,000 -119,300,000 -170,500,000 -135,000,000 -853,600,000 -120,200,000 -700,000,000 -75,600,000 -15,600,000 -15,900,000 -780,500,000 -48,200,000 -16,300,000 -17,000,000 -14,800,000 -19,000,000 -292,800,000 -16,600,000 -19,000,000 -14,500,000 -130,000,000 -52,800,000 -54,700,000 -13,300,000 -409,900,000 -12,900,000 -62,707,000 -49,528,000 -29,100,000 -16,252,000 -15,020,000 109,755,000 -67,837,000 -45,527,000 -19,480,000 -29,609,000 -28,202,000 -396,146,000 -264,868,000 
          borrowings of long-term debt
        195,400,000 692,500,000 127,900,000 168,600,000 213,600,000 265,900,000 168,400,000 1,102,900,000 192,500,000 707,200,000 92,900,000 10,600,000 15,900,000 166,600,000 38,800,000 500,000 11,900,000 6,400,000 9,900,000 282,500,000 600,000 1,400,000 139,800,000 129,800,000 158,400,000 64,400,000 3,600,000 436,500,000 2,400,000 219,982,000 41,409,000 20,976,000 374,000   96,186,000 23,592,000 69,762,000 55,523,000 24,154,000 501,268,000 110,934,000 
          payments of debt issuance costs
        -400,000 -2,500,000    200,000 -200,000   -22,800,000 -100,000 -100,000 -1,300,000     -3,000,000 -7,600,000 -1,100,000 -200,000 -1,800,000   -100,000       937,000   -1,741,000 -646,000 -11,909,000  
          distributions to non-controlling interest holders
        -58,000,000 -57,200,000 -52,500,000 -54,000,000 -62,300,000 -48,100,000 -41,700,000 -40,200,000 -40,500,000 -35,100,000 -34,100,000 -35,000,000 -41,900,000 -36,300,000 -35,300,000 -39,000,000 -36,200,000 -33,500,000 -34,100,000 -32,100,000 -31,300,000 -27,300,000 -30,600,000 -27,700,000 -24,000,000 -31,700,000 -28,600,000 -27,100,000 -33,800,000 -28,933,000 -24,315,000 -24,857,000 -30,919,000 -27,046,000 30,397,000 -17,579,000 -19,262,000 -16,335,000 -17,081,000 -14,849,000 -17,513,000 -18,525,000 
          proceeds related to ownership transactions with non-controlling interest holders
        500,000 -1,900,000 -600,000 1,400,000 1,700,000 4,000,000 4,600,000 -400,000 1,400,000                                  
          other financing activities
        400,000 7,700,000 3,700,000 1,500,000 -3,500,000 -3,500,000 -3,400,000 -4,200,000 -1,500,000 -1,400,000 -3,600,000 -4,400,000 -3,100,000 -3,600,000 -3,400,000 -3,600,000 700,000 -3,500,000 -3,500,000 -2,900,000 -8,000,000 -600,000 500,000 -800,000 100,000 100,000 -1,100,000 -101,000 -149,000 -227,000 -749,000          
          net cash from financing activities
        -55,900,000 59,200,000 -84,100,000 -62,600,000 30,200,000 48,000,000 -7,300,000 189,600,000 31,700,000 -44,600,000 -20,400,000 -49,000,000 -41,200,000 193,100,000 -48,000,000 -59,300,000 -43,700,000 229,800,000 -48,300,000 -53,000,000 187,800,000 -45,800,000 67,500,000 -35,400,000 80,400,000 -20,600,000 -44,100,000 -27,300,000 -43,900,000 121,890,000 -34,571,000 -37,923,000 -55,740,000 -43,344,000 29,661,000 2,037,000 -41,978,000 12,468,000 5,812,000 -17,727,000 70,723,000 72,254,000 
          net increase in cash and cash equivalents
        -57,600,000 36,500,000    47,700,000 8,300,000       128,100,000 -72,600,000 -151,500,000 -11,000,000                 -24,787,000   -13,733,000    77,114,000  
          cash and cash equivalents at beginning of period
        239,900,000 269,500,000 195,900,000 282,900,000 389,900,000                 144,507,000 69,699,000 57,933,000 
          cash and cash equivalents at end of period
        182,300,000 36,500,000 -46,700,000 20,800,000 229,300,000 47,700,000 8,300,000 28,300,000 185,200,000 -40,100,000 58,600,000 -68,100,000 245,500,000 128,100,000 -72,600,000 -151,500,000 378,900,000                 -24,787,000 142,667,000 1,068,000 55,966,000 14,490,000 3,610,000 -83,448,000 135,047,000 1,085,000 
          loss on debt extinguishment
                      -500,000                      
          supplemental cash flow information:
                                                  
          interest paid, net of interest income received
                                                  
          cash paid for income taxes
                                                  
          non-cash purchases of property and equipment
                                                  
          net decrease in cash and cash equivalents
           20,800,000 -40,200,000    -10,700,000  58,600,000 -68,100,000 -37,400,000                          3,610,000    
          other non-cash income
                                                  
          medicare accelerated payments and deferred governmental grants
                 -1,200,000 -4,700,000 -13,500,000 -22,200,000 -18,000,000 -25,100,000 -19,700,000 -21,600,000 -7,200,000 -5,800,000 16,300,000                    
          payment of premium on debt extinguishment
                                                 
          proceeds from equity offerings
                                                  
          payments of equity offering costs
                         -14,900,000 -100,000 -12,600,000                      
          doj settlement payments
                                                
          payments of preferred dividends
                                     -3,886,000 -3,924,000          
          receipts (payments) related to ownership transactions with non-controlling interest holders
                  100,000 -4,500,000 5,100,000      -1,000,000 2,400,000 1,000,000       -300,000 1,500,000              
          net income on disposals, consolidations and deconsolidations
                                                  
          loss on disposals and deconsolidations
                     7,900,000 2,200,000    1,900,000 1,000,000 -900,000 -1,400,000 700,000 2,900,000 3,500,000 2,600,000 600,000 -8,200,000 600,000 15,947,000 12,631,000            
          impairment charges
                                                 
          payments related to ownership transactions with non-controlling interest holders
                             -100,000         -401,000            
          proceeds from equity offering
                          260,900,000                      
          payment of preferred dividends
                          -5,100,000                      
          (payments) receipts related to ownership transactions with non-controlling interest holders
                      100,000 -900,000 -3,100,000       -1,500,000 -400,000        -782,000          
          gain on disposals and deconsolidations
                        -100,000                          
          loss on disposals
                                                  
          income from equity investments, net of distributions received
                         600,000 -200,000 -200,000 1,500,000 -800,000 -700,000 500,000 -200,000 400,000 -100,000 200,000 429,000 51,000 -559,000 322,000   626,000 -139,000 -708,000 473,000 -239,000 -372,000 -227,000 
          sale of equity investments
                                                  
          net increase in cash, cash equivalents and restricted cash
                         59,500,000 -134,400,000 -77,100,000 223,700,000 -132,100,000 123,700,000 131,700,000 101,900,000     105,185,000             
          cash, cash equivalents and restricted cash at beginning of period
                         318,200,000 93,000,000 184,600,000 175,229,000          
          cash, cash equivalents and restricted cash at end of period
                         59,500,000 -134,400,000 -77,100,000 541,900,000 -132,100,000 123,700,000 131,700,000 194,900,000 -18,600,000 -6,100,000 -25,100,000 142,800,000 105,185,000 -16,946,000 -16,747,000 113,131,000          
          adjustments to reconcile net loss to net cash from operating activities:
                                                  
          purchase of equity investments
                                                  
          repurchase of shares
                                     -1,982,000          
          gain on legal settlements
                                                  
          gain on amendment to tax receivable agreement
                                                 
          tax receivable agreement benefit
                                                  
          provision for doubtful accounts
                                      11,555,000 8,196,000 6,037,000 8,765,000  5,788,000 5,675,000 8,281,000 8,514,000 3,544,000 3,873,000 7,529,000 
          proceeds from divestitures
                                     1,139,000 7,800,000           
          penalty on prepayment of debt
                                             -4,900,000  
          proceeds from preferred stock issuance
                                                  
          payments of stock issuance costs
                                                  
          amortization of right-of-use operating lease assets
                                                  
          net decrease in cash, cash equivalents and restricted cash
                                  -6,100,000 -25,100,000 -41,800,000   -16,747,000 -62,098,000          
          non-cash interest income
                                    -300,000              
          equity-based compensation
                                    1,900,000 3,041,000 1,526,000 2,780,000 1,997,000 204,000 -386,000 1,435,000 634,000 695,000 691,000 502,000 133,000 6,223,000 
          loss on debt refinancing
                                              3,595,000 8,281,000  
          tax receivable agreement expense
                                                 
          financing lease obligation activity
                                                  
          non-cash purchases of property and equipment under capital leases and financing activities
                                        4,028,000          
          principal payments on financing lease obligations
                                      -1,587,000            
          lender financing escrow fee
                                                  
          other non-cash amortization
                                        -127,000          
          loss on disposal or impairment of long-lived assets
                                        47,000 -328,000 -1,268,000 405,000 1,196,000 658,000 572,000 1,331,000 -206,000 -575,000 
          financing lease obligations
                                        -1,506,000          
          amortization of debt issuance costs, discounts and premium
                                         -456,000         
          amortization of unfavorable lease liability
                                         -194,000 135,000 -81,000 -81,000 -108,000 -107,000 -108,000 -108,000 -108,000 
          interest on contingent consideration obligation
                                                  
          proceeds from initial public offering, net of offering costs
                                                  
          payment of premium of debt extinguishment
                                                  
          proceeds from (payments related to) ownership transactions with non-controlling interest holders
                                                  
          loss from equity investments, net of distributions received
                                                  
          financing lease obligation
                                          326,000 -293,000 -286,000 -278,000 -256,000 -219,000 -171,000 -225,000 
          benefit from doubtful accounts
                                                  
          (income) income from equity investments, net of distributions received
                                                  
          amortization of debt issuance costs and discounts
                                           1,928,000 1,846,000 1,904,000 1,947,000 1,931,000 1,417,000 1,297,000 
          receipts related to ownership transactions with consolidated affiliates
                                            154,000      
          restricted stock award vesting
                                            -649,000      
          gain on legal settlement
                                                  
          distribution to owners
                                                  
          payments related to ownership transactions with consolidated affiliates
                                                 -184,000 
          repurchase of units
                                                  
          non-cash transactions:
                                                  
          notes payable issued in connection with an acquisition
                                                  
          increase in debt related to new capital lease obligations
                                                  
          cash payments:
                                                  
          share issuance costs
                                                  
          receipts (payments) related to ownership transactions with consolidated affiliates
                                              532,000 479,000 94,000  
          goodwill impairment